Wednesday, 15 February 2012

Gastrointestinal Stromal Tumors-Food And Drug Administration-Financial Planner-Healthday News

Retiring Soon? 4 Thoughts to Consider

In the course of my work as a financial planner, I deal with many individuals who are looking to retire within the next few years. Based on my experiences advising these clients over the years, here are some thoughts for you to consider as you approach retirement. read more..


Gleevec Approval Widened to Include Rare Cancer

WEDNESDAY, Feb. 1 (HealthDay News) -- U.S. Food and Drug Administration approval for the Novartis drug Gleevec has been expanded to include adults who have had surgical removal of CD117-positive gastrointestinal stromal tumors (GIST), the agency said in a news release. read more..

No comments:

Post a Comment